Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.2951
Abstract: The optimal treatment strategy for recurrent hepatocellular carcinoma (HCC) remains unclear. Therefore, we aimed to compare the outcomes of repeat hepatic resection (RHR) and radiofrequency ablation (RFA) for recurrent HCC. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5123
Abstract: Lenvatinib is approved for the treatment of patients with metastatic or recurrent hepatocellular carcinoma (HCC); however, clinical outcomes of lenvatinib therapy in patients with post‐liver transplantation (LT) HCC recurrence remain unclear. We investigated the efficacy… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.26970
Abstract: The diagnostic efficacy of contrast‐enhanced magnetic resonance imaging (CEMRI) in diagnosing residual or recurrent hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) is currently not completely clear. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Liver Transplantation"
DOI: 10.1002/lt.26573
Abstract: To the editor, Recurrent hepatocellular carcinoma (r‐HCC) develops in >30% of patients following liver transplantation (LT) and represents a negative predictor of survival.[1] Despite this, r‐HCC after LT lacks an accepted gold‐ standard therapy supported… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-019-05733-0
Abstract: Background There is lack of data for identifying optimal local therapy for the management of recurrent hepatocellular carcinoma (HCC) after hepatic resection. Aims A retrospective study was performed to compare the effectiveness of transarterial chemoembolization… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "American journal of surgery"
DOI: 10.1016/j.amjsurg.2016.10.006
Abstract: Treatment of unresectable recurrent hepatocellular carcinoma (HCC) in patients who recur after resection or orthotopic liver transplantation (OLT) remains a clinical challenge. One option is sorafenib, although little is known about its safety and tolerance… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "International Journal of Surgery Case Reports"
DOI: 10.1016/j.ijscr.2018.11.062
Abstract: Highlights • Solitary adrenal recurrence of HCC after LDLT is extremely rare.• Strict follow up protocol is necessary to allow early detection of tumor recurrence.• Curative surgical resection of solitary recurrent HCC is a safe… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "International Journal of Hyperthermia"
DOI: 10.1080/02656736.2022.2051613
Abstract: Abstract Objectives Recurrent hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI)-positive primary tumor is at high risk of re-recurrence while treated with radiofrequency ablation (RFA). We aimed to investigate whether neoadjuvant conventional transarterial chemoembolization (cTACE)… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "BJS Open"
DOI: 10.1093/bjsopen/zrac036
Abstract: Abstract Background The efficacy of repeat hepatic resection (rHR) in the treatment of recurrent hepatocellular carcinoma compared with radiofrequency or microwave ablation after resection of the primary tumour remains controversial. A systematic review and meta-analysis… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000014498
Abstract: Aims: The aim of our systematic review was to compare the efficacy of salvage liver transplantation (SLT) versus curative locoregional therapy (CLRT) for patients with recurrent hepatocellular carcinoma (HCC). Methods: Studies comparing the SLT with… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "ANZ Journal of Surgery"
DOI: 10.1111/ans.13628
Abstract: Repeat liver resection is effective for recurrent hepatocellular carcinoma (rHCC). This study aimed to determine the outcomes of laparoscopic repeat liver resection (LRLR) for rHCC. read more here.